Stuart Lutzker
Fortune : 4 M $ au 31/08/2026
Fortune : 4 M $ au 31/08/2026
Stuart Lutzker is the founder of Arrivent BioPharma, Inc., founded in 2021, holding the titles of Director and President-Research & Development since 2022.
Former job includes VP, Head-Oncology & Early Clinical Development at Genentech, Inc. from 2004 to 2021.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York and a doctorate from Columbia University College of Physicians & Surgeons.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/04/2026 | 147 744 ( 0,32% ) | 4 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Fondateur | 14/04/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/03/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national